AKT3 and depressive disorder: Notably, in our experiments, the chronic lithium treatment known to amplified GSK3α phosphorylation at serine 21 and GSK3β at serine 9 (Mines et al., 2010; Liu et al., 2011), is able to reverse the behavioral signs of anxiety and depression observed in Akt3 KO mice.